Amneal Pharmaceuticals
Stock Forecast, Prediction & Price Target
Amneal Pharmaceuticals (AMRX) stock Price Target by analysts
$11
Potential upside: 20.08%
Amneal Pharmaceuticals price prediction
What is Amneal Pharmaceuticals stock analysts` prediction?
Amneal Pharmaceuticals stock forecast: Based on 2 Wall Street analysts` predicted price targets for Amneal Pharmaceuticals in the last 3 months, the avarage price target is $11, with a high forecast of $NaN. The average price target represents a 20.08% change from the last price of $9.16.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Amneal Pharmaceuticals stock Price Target by analysts
Full breakdown of analysts given Amneal Pharmaceuticals price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
David Amsellem Piper Sandler | 0% 0/2 | 10 months ago | $11 20.08% upside | $8.29 | StreetInsider | Previous targets (1) |
Les Sulewski Truist Financial | 0% 0/3 | 11 months ago | $12 31.00% upside | $8.7 | TheFly | Previous targets (2) |
Les Sulewski Truist Financial | 0% 0/3 | 11 months ago | $10 9.17% upside | $8.7 | StreetInsider | Previous targets (2) |
Les Sulewski Truist Financial | 0% 0/3 | over 1 year ago | $9 -1.74% downside | $6.76 | StreetInsider | Previous targets (2) |
David Amsellem Piper Sandler | 0% 0/2 | over 1 year ago | $8 -12.66% downside | $6.29 | StreetInsider | Previous targets (1) |
Unknown Goldman Sachs | N/A | about 3 years ago | $4 -56.33% downside | $3.22 | Benzinga | N/A |
Amneal Pharmaceuticals Financial Estimates
Amneal Pharmaceuticals Revenue Estimates
Amneal Pharmaceuticals EBITDA Estimates
Amneal Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $2.09B N/A | $2.21B 5.66% | $2.39B 8.19% | Avg: $2.79B Low: $2.74B High: $2.84B avg. 16.56% | Avg: $2.89B Low: $2.83B High: $2.95B avg. 3.59% | ||
Net Income
% change YoY
| $20.17M N/A | $-254.78M -1363.20% | $-83.99M 67.03% | Avg: $23.06M Low: $11.99M High: $12.67M avg. 127.46% | Avg: $18.4M Low: $0 High: $0 avg. -20.22% | ||
EBITDA
% change YoY
| $442.64M N/A | $446.63M 0.90% | $500.78M 12.12% | Avg: $449.77M Low: $443.21M High: $457.98M avg. -10.18% | Avg: $465.93M Low: $456.26M High: $475.94M avg. 3.59% | ||
EPS
% change YoY
| $0.14 N/A | -$1.69 -1307.14% | -$0.48 71.59% | Avg: $0.07 Low: $0.07 High: $0.07 avg. 114.58% | Avg: $0 Low: $0 High: $0 avg. -100% | ||
Operating Expenses
% change YoY
| $575.06M N/A | $595.78M 3.60% | $616.19M 3.42% | Avg: $489.26M Low: $482.12M High: $498.19M avg. -20.59% | Avg: $506.83M Low: $496.32M High: $517.72M avg. 3.59% | ||
FAQ
What is Amneal Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 53.61% in 2025-2026.
We have gathered data from 3 analysts. Their low estimate is 11.99M, average is 23.06M and high is 12.67M.
What is Amneal Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 10.07% in 2025-2026.
We have gathered data from 4 analysts. Their low revenue estimate is $2.74B, average is $2.79B and high is $2.84B.
What is Amneal Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 57.29% in 2025-2026.
We have gathered data from 3 analysts. Their low earnings per share estimate is $0.07, average is $0.07 and high is $0.07.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Amneal Pharmaceuticals stock. The most successful analyst is David Amsellem.